Tie-breakers are cruel but there's no better way

India, June 30 -- Michel Platini, Zico and Socrates scored six international penalty goals each. Platini and Socrates never missed from the spot during regulation time for France and Brazil. Neither h... Read More

'Mr Joachim Klement, please try again': Neymar roasts economist whose World Cup model predicted Brazil's downfall

HOUSTON, June 30 -- Brazil may have left it late to book their place in the 2026 Fifa World Cup Round of 16, but Neymar wasted no time delivering a cheeky message to one man who had already written th... Read More

Main Wapas Aaunga Box Office Collection Day 18: Imtiaz Ali's Film Shows Resilience In Long Theatrical Journey; Crosses Rs 73.01Crore Worldwide With Rs 47.80 Crore Net

India, June 30 -- Imtiaz Ali's romantic drama Main Vaapas Aaunga has reached a really notable box office mark, with Rs.73.01 crore worldwide by its 18th day running in theatres. The film's emotional s... Read More

From brain drain to brain gain: Academically Global achieves 100% placement for first batch of healthcare upskilling programme

New Delhi, June 30 -- Academically Global, a healthcare education and career transformation platform founded by Australia-trained healthcare educator Dr Akram Ahmad, has announced 100% placement succe... Read More

Yen at record low: What it means for the Japanese economy

Tokyo, June 30 -- Japan's currency Yen sank to a 40-year low against the US dollar on Tuesday, triggering fears that it could prompt a quick intervention from the central bank. The weakness in the Ja... Read More

Singapore Clinical Trial: A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Study to Evaluate the Gastric Emptying Delay, Pharmacokinetics, Safety, and Tolerability of Eloralintide in Participants with Obesity or Overweight

Singapore, June 30 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose St... Read More

Singapore Clinical Trial: A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating the safety and tolerability of ARD001 in healthy adult subjects and a Phase 2 open-label, multiple-dose study in adult subjects with hemophilia A

Singapore, June 30 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... Read More

Singapore Clinical Trial: A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Open-Label Extension to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Radiprodil in Participants With GRIN-Related Neurodevelopmental Disorder

Singapore, June 30 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More

Singapore Clinical Trial: A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solution for Injection (TLX101-Tx) Plus Lomustine Versus Lomustine Alone in Patients with Radiographically Confirmed Recurrent Glioblastoma at First Recurrence (IPAX-3)

Singapore, June 30 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... Read More

Singapore Clinical Trial: RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients with Metastatic Pancreatic Adenocarcinoma

Singapore, June 30 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... Read More

• ««
• «
• 12393
• 12394
• 12395
• 12396
• 12397
• 12398
• 12399
• 12400
• 12401
• 12402
• »
• »»